Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia (Q24200304)

title

Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

1 reference

1 reference

1 reference

2

0 references

Helle Krogh Johansen

4

0 references

Karsten Juhl Jørgensen

1

0 references

Peter C. Gøtzsche

2

object named as

Peter C Gøtzsche

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

Karsten Juhl Jørgensen

1

object named as

Karsten Juhl Jørgensen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

4

Helle Krogh Johansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

author name string

Christina S Dalbøge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

24 February 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

page(s)

CD004707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Voriconazole versus amphotericin B for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Antifungal therapy in 'bone marrow failure'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004707.PUB3

Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Nystatin prophylaxis and treatment in severely immunodepressed patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Voriconazole: a new triazole antifungal agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Candida infections in bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

Role of surveillance cultures in prevention and treatment of fungal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563222

12 December 2020

10.1002/14651858.CD004707.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457750&resulttype=core&format=json

13 May 2020

PubMed publication ID

24563222

1 reference